150 related articles for article (PubMed ID: 37580851)
1. Patent foramen ovale in carcinoid heart disease: The potential role for and risks of percutaneous closure prior to cardiothoracic surgery.
Douglas S; Oelofse T; Shah T; Rooney S; Arif S; Steeds RP
J Neuroendocrinol; 2023 Aug; 35(8):e13323. PubMed ID: 37580851
[TBL] [Abstract][Full Text] [Related]
2. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
Hayashi Y; McGaw DJ; Goldstein J
Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
4. Development of severe intrapulmonary shunting in a patient with carcinoid heart disease after closure of a persistent foramen ovale: a case report.
Schüttler D; Mourouzis K; Auernhammer CJ; Rizas KD
Eur Heart J Case Rep; 2021 Dec; 5(12):ytab494. PubMed ID: 35047738
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale in carcinoid heart disease.
Mansencal N; Touhami I; Mitry E; Rougier P; Dubourg O
Int J Cardiol; 2010 Jul; 142(2):e29-31. PubMed ID: 19157592
[TBL] [Abstract][Full Text] [Related]
6. Profound hypoxaemia corrected by PFO closure device in carcinoid heart disease.
Mottram PM; McGaw DJ; Meredith IT; Peverill RE; Harper RW
Eur J Echocardiogr; 2008 Jan; 9(1):47-9. PubMed ID: 17018264
[TBL] [Abstract][Full Text] [Related]
7. Assessment of patent foramen ovale in carcinoid heart disease.
Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of left-sided carcinoid heart disease.
Connolly HM; Schaff HV; Mullany CJ; Rubin J; Abel MD; Pellikka PA
Circulation; 2001 Sep; 104(12 Suppl 1):I36-40. PubMed ID: 11568027
[TBL] [Abstract][Full Text] [Related]
9. Flow-driven right-to-left cardiac shunting in a patient with carcinoid heart disease and patent foramen ovale without elevated right atrial pressure: a case report and literature review.
Dherange P; Telles N; Modi K
Eur Heart J Case Rep; 2020 Dec; 4(6):1-5. PubMed ID: 33442599
[TBL] [Abstract][Full Text] [Related]
10. Relentless Hypoxia in a Patient With Carcinoid Syndrome.
Alghamdi A; Malibari AA; Al-Husayni F; Jabri A; Albugami S
Cureus; 2021 Dec; 13(12):e20497. PubMed ID: 35047309
[TBL] [Abstract][Full Text] [Related]
11. NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt: A Multi-imaging Challenge to Nuclear Medicine.
Laschinsky C; Welsner M; Mahabadi AA; Lahner H; Hautzel H
Clin Nucl Med; 2024 Feb; 49(2):157-159. PubMed ID: 38178372
[TBL] [Abstract][Full Text] [Related]
12. Echo rounds: Undiagnosed severe pulmonic regurgitation in a carcinoid patient for tricuspid valve replacement and patent foramen ovale closure.
Hastie MJ; Souh J; Ju A; Shanewise JS
Anesth Analg; 2013 Feb; 116(2):300-2. PubMed ID: 23302967
[No Abstract] [Full Text] [Related]
13. A Case of Carcinoid Syndrome Due to Malignant Metastatic Carcinoid Tumor with Carcinoid Heart Disease Involving Four Cardiac Valves.
Shinn BJ; Tafe LJ; Vanichakarn P
Am J Case Rep; 2018 Mar; 19():284-288. PubMed ID: 29527003
[TBL] [Abstract][Full Text] [Related]
14. Resting arterial hypoxaemia in subjects with chronic heart failure, pulmonary hypertension and patent foramen ovale.
Lovering AT; Lozo M; Barak O; Davis JT; Lojpur M; Lozo P; Čaljkušić K; Dujić Ž
Exp Physiol; 2016 May; 101(5):657-70. PubMed ID: 26990684
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid heart disease of gonadal primary presenting with hypoxia: a case report.
O'Driscoll R; Prashar A; Youssef G; Sader M
Eur Heart J Case Rep; 2021 May; 5(5):ytaa536. PubMed ID: 34124556
[TBL] [Abstract][Full Text] [Related]
16. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome.
Mojadidi MK; Gevorgyan R; Noureddin N; Tobis JM
Catheter Cardiovasc Interv; 2015 Oct; 86(4):701-7. PubMed ID: 26063336
[TBL] [Abstract][Full Text] [Related]
17. Platypnoea Orthodeoxia Syndrome and Patent Foramen Ovale Closure: Single-Centre Experience and Long-Term Follow-Up.
Gama E Castro A; Luz A; Oliveira F; Brochado B; Santos R; Alexandre A; Campinas A; Couto DS; Silveira J; Torres S
Heart Lung Circ; 2022 Nov; 31(11):1547-1552. PubMed ID: 35987719
[TBL] [Abstract][Full Text] [Related]
18. Migration of PFO closure device and entrapment within tricuspid valve leading to tricuspid regurgitation: surgical correction of an extremely rare complication after transcutaneous PFO closure.
Thet MS; Sepehripour A; Atieh AEFA; Di Salvo C
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33500310
[TBL] [Abstract][Full Text] [Related]
19. [Progressive dyspnoea in two patients with carcinoid syndrome].
Nölting S; Nicolaus M; Behr J; Baumgartner R; Mete H; Boekstegers P; Herrmann K; Theisen D; Lehrke M; Göke B; Schirra J; Auernhammer CJ
Internist (Berl); 2010 Nov; 51(11):1439-45. PubMed ID: 20628718
[TBL] [Abstract][Full Text] [Related]
20. Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review.
Blanche C; Noble S; Roffi M; Testuz A; Müller H; Meyer P; Bonvini JM; Bonvini RF
Eur J Intern Med; 2013 Dec; 24(8):813-7. PubMed ID: 24007641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
